This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Viral Infections  • Hearing Loss/ Deafness  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

David R. White, MD; Daniel I. Choo, MD; Greg Stroup, BS; Mark R. Schleiss, MD

Arch Otolaryngol Head Neck Surg. 2006;132:608-615.

Objective  To evaluate the utility of therapy with the cyclic cogener of the anti-cytomegalovirus (CMV) agent cidofovir against CMV-induced hearing loss in a guinea pig model.

Design  Thirty-six guinea pigs were randomly divided into 4 groups of 9. All groups underwent auditory brainstem response testing on days 0, 4, 7, 14, 21, and 28. Group 1 received no intervention. Group 2 underwent sham surgery consisting of unilateral round window injection of 25 µL of sterile viral media on day 0. Groups 3 and 4 underwent round window injection of 1.7 x 10⁵ plaque-forming units of guinea pig CMV on day 0. Group 4 received antiviral treatment with intraperitoneal injection of cidofovir (20 mg/kg) on days 1 and 5 after inoculation.

Setting  An animal research facility.

Subjects  Thirty-six weanling Hartley guinea pigs.

Results  Of the animals who received guinea pig CMV and no cidofovir treatment, 4 of 9 (day 4) and 5 of 9 (days 7 and 28) demonstrated a hearing loss of at least 30 dB. In contrast, none of the animals in the untreated, sham surgery, or cidofovir-treated groups had a hearing loss of greater than 20 dB. This difference was statistically significant for day 4 (P = .04, 1-tailed Fisher exact test), day 7 (P = .01), and day 28 (P = .01). Histologic evaluation of hearing-impaired animals revealed inflammatory infiltrates, particularly in the scala tympani. Fibrosis of the basal turn of the cochlea was observed in 7 of 9 untreated animals and 1 of 9 treated animals.

Conclusion  Cidofovir therapy prevents CMV-induced hearing loss and associated histologic changes in guinea pigs.

Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina, Charleston (Dr White); Department of Pediatric Otolaryngology–Head and Neck Surgery (Dr Choo) and Division of Experimental Hematology (Mr Stroup), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and Division of Pediatric Infectious Diseases and Immunology, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis (Dr Schleiss).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?